Upcoming Webinars

ISRS delivers its 128th Webinar

Since we launched our webinar program in Oct. 2016 we have delivered webinars on a fortnightly basis covering important topics related to intracranial and body SRS. These have become increasingly popular during the pandemic, attracting hundreds of registrants. We have now completed more than 120 webinars. This has been made possible due to the generosity of the speakers who have given their time to present high level lectures. Members can access recordings of all of the webinars via our website: Access the library here.

Upcoming Webinars

The Current Landscape of Spine Radiosurgery

by Kartik MANI, MD, PhD

Clinical Assistant Professor, Radiation Oncology 

Clinical Division Head Co-Chair

Spine Tumor Working Group Department of Radiation Oncology Department of Biomedical Informatics 

Stony Brook University Hospital, NY, USA

August 26, 2022, 1:00PM BST

Stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) are increasingly being utilized to treat metastatic patients, particularly those with a limited number of lesions (oligometastatic).  Patients with spinal metastases present unique challenges but are also benefiting significantly from this trend.  In this talk we will review the current evidence regarding the use of SRS/SBRT for spinal metastases, and discuss ongoing studies and future directions for multidisciplinary spine management.


Oligometastases to and from the lung – the role of SABR

by Shankar SIVA, MD

Radiation Oncologist

Lung and Kidney Cancer; Stereotactic Ablative Body Radiotherapy (SABR)
Peter MacCallum Cancer Centre
Melbourne, Australia

September 26, 2022, 1:00PM BST

Oligometastatic disease is one of the most topical areas in radiation oncology in the present era. Several key trials have embedded the use of stereotactic ablative body radiotherapy (SABR) in the modern oncological armamentarium. However there are several key considerations for routine clinical practice; these include the optimal dose, sequencing, safety, combinations with systemic therapy and indications for the use of SABR in oligometastatic disease. This webinar will focus on two closely interrelated scenarios - the use of SABR in a) oligometastatic disease originating from lung cancer and b) pulmonary oligometastases. We will discuss the current state of evidence in the field, current controversies, and future directions.


Meningiomas - Single or More than 1 Fraction?

by Robert SMEE, Professor

Radiation Oncologist

Department Of Radiation Oncology

Nelune Comprehensive Cancer Centre

Prince Of Wales Hospital    

Randwick, NSW, Australia

October 27, 2022, 1:00PM BST

Meningiomas are typically benign intracranial tumours, more common in females than males. A common site of presentation involves the cavernous sinus, with cranial nerve deficits a relatively routine feature at diagnosis. Proximity to the optic nerve/chiasm is a determinant of how radiotherapy is delivered. The end point for benefit, as with most benign tumours, is lack of progression, achieved in typically greater than 90% of treated patients, irrespective of modality.